Integra LifeSciences is a global medical device manufacturer that develops, manufactures, and distributes surgical instruments, wound care solutions, and regenerative tissue products—including a significant portion containing bovine-derived materials—to hospitals, surgical centers, and healthcare providers worldwide. The company operates under stringent regulatory oversight from the FDA and international regulatory bodies, including the EU Medical Device Regulation, which requires extensive compliance investments, clinical trials, and quality assurance procedures; it also navigates complex reimbursement dynamics tied to healthcare reform, cost-containment policies, and government programs such as Medicare and Medicaid. Revenue is generated through device sales, though growth and profitability depend on timely regulatory clearances, pricing approvals, market adoption, and the company's ability to manage manufacturing quality and regulatory compliance across multiple jurisdictions.